MENU
AUG 31, 2017 7:00 AM PDT

Characterization of H4-IC31 candidate: particles and composition

Speakers
  • Associate Scientist at SGS Canada and Sanofi Pasteur Ltd., Toronto, ON
    Biography
      Sasmit Deshmukh is an Associate Scientist at SGS Canada and Sanofi Pasteur Ltd., Toronto, ON. He received his PhD in Chemistry at Concordia University, Montreal, QC. He has over 10 years of extensive multidisciplinary research experience in chemistry, biochemistry and biophysics.
    • Head of Biophysics and Conformation Unit, Biochemistry Platform, Analytical R&D North America, Sanofi Pasteur Ltd
      Biography
        Marina Kirkitadze is Head of Biophysics and Conformation Unit, Biochemistry Platform, Analytical R&D North America, Sanofi Pasteur Ltd. She has 15 years' experience in the vaccine industry. Marina received her PhD in Biological Sciences at the Institute of Protein Research, Russian Academy of Sciences, Pushchino, Russia, and her MBA from the University of Phoenix, AZ, USA.

      Abstract

      DATE: August 31, 2017
      TIME: 7:00am PT, 10:00am ET, 4:00pm CET

      A tuberculosis (TB) vaccine consisting of a recombinant fusion protein (referred to as H4) combined with a novel synthetic cationic adjuvant, IC31®, is in development. The H4 fusion protein consists of two immunogenic mycobacterial antigens, Ag85B and TB10.4. The IC31® adjuvant is a mixture of KLK, a leucine-rich peptide (KLKL5KLK), and the oligodeoxynucleotide ODN1a, a TLR9 ligand.  This webinar will discuss Phase Analysis Light Scattering (PALS) and Raman spectroscopy methods to characterize the H4-IC31 vaccine formulation. The PALS method can be used to assess vaccine product quality and consistency in terms of particle size, zeta potential and conductivity. These parameters can differentiate between the IC31® adjuvant and the H4-IC31 vaccine candidate; hence, the method can serve as a control during vaccine formulation. Additionally, Electrical Sensing Zone (ESZ) was used as an orthogonal method to measure size of IC31 and H4-IC31 particles. Furthermore structural changes of H4 protein upon adjuvantation were characterized by Raman, FTIR and CD spectroscopy. The applicability of these biophysical methods to characterize vaccine components in the final H4-IC31 drug product without desorption will be discussed. 


      Show Resources
      You May Also Like
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      JUN 02, 2020 9:00 AM PDT
      C.E. CREDITS
      JUN 02, 2020 9:00 AM PDT
      DATE: June 2, 2020 TIME: 9:00am PT, 12:00pm ET Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the m...
      APR 27, 2020 9:00 AM PDT
      C.E. CREDITS
      APR 27, 2020 9:00 AM PDT
      DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
      AUG 18, 2020 10:00 AM PDT
      C.E. CREDITS
      AUG 18, 2020 10:00 AM PDT
      DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
      MAY 04, 2020 9:00 AM PDT
      C.E. CREDITS
      MAY 04, 2020 9:00 AM PDT
      DATE: May 4, 2020 TIME: 9:00am PT, 12:00pm ET...
      NOV 10, 2020 7:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      NOV 10, 2020 7:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
      Loading Comments...
      Show Resources
      Attendees
      • See more